New multicenter US data show that a single respiratory syncytial virus (RSV) vaccine dose protects against hospitalization in older adults, though effectiveness wanes over time and is lower in...
In a phase 1 trial, a single injection of an mRNA RSV vaccine boosted neutralizing antibody levels in seropositive children and was well tolerated, with no serious adverse events or study discontinuations...
This respiratory disease roundup covers the potential impact of a new COVID-19 variant, changes in funding for pandemic influenza vaccines, and a study on cardiac event risks in respiratory syncytial virus...
From respiratory syncytial virus monoclonal antibody approvals to thimerosal-free vaccine preferences, ACIP’s latest guidance has important implications for your practice.
A new randomized trial in newly formed heterosexual couples investigated whether recent human papillomavirus vaccination protects individuals or their partners against transmission.
A multilevel intervention improved human papillomavirus vaccine initiation and completion among most children aged 11 to 12 years, though the effect was limited for those living in under-resourced settings,...
New research shows stalled childhood vaccine progress, elevated heart risks linked to COVID-19 vaccines in young men, and rising gastrointestinal disorders during the pandemic.
A national analysis of county-level measles-mumps-rubella vaccination rates from 2017 to 2024 shows a significant decline following the COVID-19 pandemic, with geographic variation and implications for...
Secretary Robert F. Kennedy Jr. announced that the CDC will no longer recommend the COVID-19 booster vaccine for healthy children and pregnant people. The announcement comes despite previous CDC...
